These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 14980648)
61. [Bisphosphonates inhibit matrix metalloproteinases--a new possible mechanism of action]. Teronen O; Konttinen YT; Salo T; Lindqvist C; Heikkilä P; Laitinen M; Sorsa T Duodecim; 1999; 115(1):13-5. PubMed ID: 11830856 [No Abstract] [Full Text] [Related]
62. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo. Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568 [TBL] [Abstract][Full Text] [Related]
63. Targeting matrix metalloproteinases: design of a bifunctional inhibitor for presentation by tumour-associated galectins. Bartoloni M; Domínguez BE; Dragoni E; Richichi B; Fragai M; André S; Gabius HJ; Ardá A; Luchinat C; Jiménez-Barbero J; Nativi C Chemistry; 2013 Feb; 19(6):1896-902. PubMed ID: 23280962 [TBL] [Abstract][Full Text] [Related]
64. Sulphonamides: Deserving class as MMP inhibitors? Jain P; Saravanan C; Singh SK Eur J Med Chem; 2013 Feb; 60():89-100. PubMed ID: 23287054 [TBL] [Abstract][Full Text] [Related]
65. Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors. Zhong HA; Arbiser J; Bowen JP Curr Pharm Des; 2013; 19(26):4701-13. PubMed ID: 23260023 [TBL] [Abstract][Full Text] [Related]
66. Enzymatic activation of a matrix metalloproteinase inhibitor. Major Jourden JL; Cohen SM Chem Commun (Camb); 2010 Feb; 46(8):1241-3. PubMed ID: 20449263 [TBL] [Abstract][Full Text] [Related]
68. The next generation of MMP inhibitors. Design and synthesis. De B; Natchus MG; Cheng M; Pikul S; Almstead NG; Taiwo YO; Snider CE; Chen L; Barnett B; Gu F; Dowty M Ann N Y Acad Sci; 1999 Jun; 878():40-60. PubMed ID: 10415719 [TBL] [Abstract][Full Text] [Related]
69. Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors. Jourden JL; Daniel KB; Cohen SM Chem Commun (Camb); 2011 Jul; 47(28):7968-70. PubMed ID: 21677985 [TBL] [Abstract][Full Text] [Related]
70. Role of matrix metalloproteinases in mesangial proliferative glomerulonephritis. Marti HP Kidney Blood Press Res; 2000; 23(3-5):199-201. PubMed ID: 11031721 [No Abstract] [Full Text] [Related]
79. Matrix metalloproteinases in thyroid cancer. Shi Y; Zou M Cancer Treat Res; 2004; 122():179-90. PubMed ID: 16209045 [No Abstract] [Full Text] [Related]